Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey

被引：15

作者：

Esel, D ^{[1
]}

Doganay, M

Sumerkan, B

机构：

[1] Erciyes Univ, Fac Med, Dept Microbiol, TR-38039 Kayseri, Turkey

[2] Erciyes Univ, Fac Med, Dept Infect Dis, TR-38039 Kayseri, Turkey

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2003年 / 22卷 / 01期

关键词：

Bacillus anthracis; antimicrobial susceptibility; quinolones;

D O I：

10.1016/S0924-8579(03)00097-9

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Forty clinical isolates of Bacillus anthracis were studied. The MIC90 values of penicillin G, doxycycline, ciprofloxacin, gatifloxacin, and levofloxacin were 0.016, 0.03, 0.06, 0.06 and 0.12 mg/l, respectively. Susceptibilities suggest that the quinolones may also be considered as an alternative therapy for anthrax. (C) 2003 Elsevier Science B.V. and the International Society of Chemotherapy. All rights reserved.

引用

页码：70 / 72

页数：3

共 16 条

[1] Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000 [J].

Cavallo, JD ;

Ramisse, F ;

Girardet, M ;

Vaissaire, J ;

Mock, M ;

Hernandez, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) :2307-2309

[2] In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne [J].

Choe, CH ;

Bouhaouala, SS ;

Brook, I ;

Elliott, TB ;

Knudson, GB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1766-1766

[3] ANTIMICROBIAL SUSCEPTIBILITY OF BACILLUS-ANTHRACIS [J].

DOGANAY, M ;

AYDIN, N .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, 23 (03) :333-335

[4]

DOGANAY M, 1990, SALISBURY MED B S, V68, P13

[5]

Elliott Thomas B, 2002, Mil Med, V167, P103

[6] Terrorism from a public health perspective [J].

Evans, RG ;

Crutcher, JM ;

Shadel, B ;

Clements, B ;

Bronze, MS .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 323 (06) :291-298

[7] Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States [J].

Jernigan, JA ;

Stephens, DS ;

Ashford, DA ;

Omenaca, C ;

Topiel, MS ;

Galbraith, M ;

Tapper, M ;

Fisk, TL ;

Zaki, S ;

Popovic, T ;

Meyer, RF ;

Quinn, CP ;

Harper, SA ;

Fridkin, SK ;

Sejvar, JJ ;

Shepard, CW ;

McConnell, M ;

Guarner, J ;

Shieh, WJ ;

Malecki, JM ;

Gerberding, JL ;

Hughes, JM ;

Perkins, BA .

EMERGING INFECTIOUS DISEASES, 2001, 7 (06) :933-944

[8] Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization [J].

Kobiler, D ;

Gozes, Y ;

Rosenberg, H ;

Marcus, D ;

Reuveny, S ;

Altboum, Z .

INFECTION AND IMMUNITY, 2002, 70 (02) :544-550

[9]

Lightfoot N.F., 1990, Salisbury Med. Bull, V68, P95

[10]

Logan N.A., 1999, MANUAL CLIN MICROBIO, P357

← 1 2 →